Literature DB >> 5811648

Management of primary and secondary hyperaldosteronism.

.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5811648      PMCID: PMC1984222          DOI: 10.1136/bmj.3.5668.427-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

Review 1.  ALDOSTERONE AND ITS ANTAGONISTS.

Authors:  E J ROSS
Journal:  Clin Pharmacol Ther       Date:  1965 Jan-Feb       Impact factor: 6.875

2.  The effects of spironolactone and chlorthalidone on arterial pressure.

Authors:  W I CRANSTON; B E JUEL-JENSEN
Journal:  Lancet       Date:  1962-06-02       Impact factor: 79.321

3.  The world's children and tomorrow.

Authors:  M PATE
Journal:  Fed Proc       Date:  1961-03

4.  Aldosteronism and arterial hypertension.

Authors:  J H LARAGH
Journal:  Med Clin North Am       Date:  1961-03       Impact factor: 5.456

5.  Hypertension caused by renal artery occlusion simulating primary aldosteronism.

Authors:  J C LAIDLAW; E R YENDT; A G GORNALL
Journal:  Metabolism       Date:  1960-07       Impact factor: 8.694

6.  Complications of diuretic therapy in hepatic cirrhosis.

Authors:  S Sherlock; B Senewiratne; A Scott; J G Walker
Journal:  Lancet       Date:  1966-05-14       Impact factor: 79.321

7.  Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.

Authors:  J P Radó; J Marosi; J Takó; I Dévényi
Journal:  Am Heart J       Date:  1968-09       Impact factor: 4.749

8.  Aldosteronism in hypertension. The spironolactone response test.

Authors:  R F Spark; J C Melby
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

9.  Aldosterone secretion in hypertension.

Authors:  J M George; L Gillespie; F C Bartter
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

10.  Aldosterone antagonists and triamterene.

Authors:  G W Liddle
Journal:  Ann N Y Acad Sci       Date:  1966-11-22       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.